Lymphomatoid Granulomatosis

hematologic malignancy

Identifier: CI-CAN-00001104
Entity page: /cancer/lymphomatoid-granulomatosis ↗
Edges: 130

Neighbours: 15 drugs10 trials
Drawn: 25 of 25 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,149 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Lymphomatoid Granulomatosis investigated in trials for …INVESTIGATED_IN_TRIALSderived15 of 47show all (up to 200)
→ investigated in trials for	Fludarabinesmall molecule 17 trials (0 active) · roll-up of the cancer and its descendants	—	—	Lymphomatoid Granulomatosis	17	Observed	clinicaltrials	graph →
→ investigated in trials for	Rituximabmonoclonal antibody

Lymphomatoid Granulomatosis studied in …STUDIED_INderived10 of 83show all (up to 200)
→ studied in	NCT01676805recruiting Tissue Collection for Studies of Lymph Cancer · condition mapped ONTOLOGY_EXACT · 83 trials mapped (4 active)	—	—	Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT01815749Phase 1 · active not recruiting Genetically Modified T-cell Infusion Following Peripheral Blood Stem Cell Transplant in Treating Patients With Recurrent or High-Risk Non-Hodgkin Lymphoma · condition mapped ONTOLOGY_EXACT · 83 trials mapped (4 active)	—	—	Adult Grade III Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT03038672Phase 2 · active not recruiting Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas · condition mapped CURATED_BROADER · 83 trials mapped (4 active)	—	—	Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped CURATED_BROADER · 83 trials mapped (4 active)	—	—	Adult Grade III Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT02213913Phase 1/Phase 2 · completed Lenalidomide and Combination Chemotherapy (DA-EPOCH-R) in Treating Patients With MYC-Associated B-Cell Lymphomas · condition mapped ONTOLOGY_EXACT · 83 trials mapped (4 active)	—	—	Adult Grade III Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT01199562active not recruiting Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant · condition mapped ONTOLOGY_EXACT · 83 trials mapped (4 active)	—	—	Adult Grade III Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT00001379Phase 2 · completed Treatment and Natural History Study of Lymphomatoid Granulomatosis · condition mapped ONTOLOGY_EXACT · 83 trials mapped (4 active)	—	—	Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT01769222Phase 1 · terminated Ipilimumab and Local Radiation for Selected Solid Tumors · condition mapped CURATED_BROADER · 83 trials mapped (4 active)	—	—	Adult Grade III Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT01523223Phase 1 · completed Donor Peripheral Stem Cell Transplant in Treating Patients With Hematolymphoid Malignancies · condition mapped CURATED_BROADER · 83 trials mapped (4 active)	—	—	Adult Grade III Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →
→ studied in	NCT01044745Phase 2 · terminated Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer · condition mapped CURATED_BROADER · 83 trials mapped (4 active)	—	—	Adult Grade III Lymphomatoid Granulomatosis	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains